Lumbard & Kellner’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Lumbard & Kellner’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$977K	Buy	+6,174	New	+$835K	0.3%	61
2025 Q3	–	Sell	-55,089	Closed	-$4.57M	–	99
2025 Q2	$4.57M	Sell	55,089 -21,806	-28%	-$1.74M	1.99%	21
2025 Q1	$6.24M	Buy	76,895 +585	+0.8%	+$52.3K	2.75%	13
2024 Q4	$6.87M	Sell	76,310 -3,703	-5%	-$359K	2.95%	9
2024 Q3	$7.91M	Buy	80,013 +28,101	+54%	+$2.76M	3.48%	8
2024 Q2	$4.81M	Sell	51,912 -157	-0.3%	-$14.1K	2.27%	17
2024 Q1	$4.94M	Buy	52,069 +310	+0.6%	+$28.8K	2.4%	17
2023 Q4	$4.62M	Buy	+51,759	New	+$3.84M	2.68%	17

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Lumbard & Kellner's XBI Position: Q2 2026 in Review

Lumbard & Kellner opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 6,174 shares worth $977K. The stake represents 0.3% of the portfolio and ranks #61 among its holdings. This is a return to the name: Lumbard & Kellner previously reported a position in XBI as recently as Q2 2025.

Lumbard & Kellner first reported a position in XBI in Q4 2023 and has held it in 8 quarters since. The position peaked at $7.91M in Q3 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Lumbard & Kellner held 6,174 shares of State Street SPDR S&P Biotech ETF worth $977K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Lumbard & Kellner position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.3% of Lumbard & Kellner's portfolio in Q2 2026, its #61 holding.
Lumbard & Kellner first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 8 quarters since.
Lumbard & Kellner's State Street SPDR S&P Biotech ETF position peaked at $7.91M in Q3 2024.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Lumbard & Kellner's 13F filing for Q2 2026, filed 6 Aug 2026.